Caliper Life Sciences: Interview with Kevin Hrusovsky, CEO
5d 1m 3m 1y 5y 10y
CALP vs. ETF Alternatives
Thursday, Sep 82011, 9:00 AM
Thursday, Sep 82011, 7:12 AMPerkinElmer (PKI) agrees to buy Caliper Life Sciences (CALP) for $10.50 a share, a 42% premium over yesterday's closing price. The $600M deal adds "innovative molecular imaging and detection technologies" to PerkinElmer's portfolio, according to its CEO. Shares of CALP +40% premarket. |Thursday, Sep 82011, 7:12 AM| Comment!
Tuesday, Feb 12011, 11:39 AMWith the 2011 Advances in Genome Biology and Technology conference getting underway tomorrow, life sciences companies may get a little extra attention. Major presenters/participants include Illumina (ILMN), Life Technologies (LIFE), Caliper Life Sciences (CALP), Agilent (A), Pacific Biosciences (PACB), and Complete Genomics (GNOM). |Tuesday, Feb 12011, 11:39 AM| Comment!
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.